Transplantation and Cellular Therapy
Displaying 1 - 17 of 17
Katsivelos, N., Spyrou, N., Weber, D., Vasova, I., Ayuk, F., Choe, H., Hogan, W., DeFilipp, Z., Qayed, M., Etra, A. M., Sandhu, K., Kraus, S., Olson, T., Hexner, E., Aguayo-Hiraldo, P., Reshef, R., Ullrich, E., Schechter, T., Kitko, C., … Levine, J. E. (2024). Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2024.10.012
Publication Date
Columbia Affiliation
Goyal, A., O’Leary, D., Dabaja, B., Weng, W.-K., Zain, J., Cutler, C., Guitart, J., Kim, Y. H., Geskin, L. J., Hoppe, R. T., Wilson, L. D., Beaven, A. W., Horwitz, S., Allen, P. B., Barta, S. K., Bohjanen, K., Brammer, J. E., Carter, J. B., Comfere, N., … Foss, F. (2024). ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome. Transplantation and Cellular Therapy, 30(11), 1047–1060. https://doi.org/10.1016/j.jtct.2024.08.020
Publication Date
Columbia Affiliation
Rios, C. A. O., Qayed, M., Etra, A. M., Reshef, R., Newcomb, R., Yuhasz, N., Hexner, E. O., Aguayo-Hiraldo, P., Merli, P., Hogan, W. J., Weber, D., Kitko, C. L., Ayuk, F., Eder, M., Grupp, S. A., Kraus, S., Sandhu, K., Ullrich, E., Vasova, I., … Akahoshi, Y. (2024). Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. Transplantation and Cellular Therapy, 30(11), 1061.e1-1061.e10. https://doi.org/10.1016/j.jtct.2024.08.019
Publication Date
Columbia Affiliation
George, S. A., Veludhandi, A., Xiang, Y., Liu, K., Stenger, E., Arnold, S. D., Mehta, A., Schirmer, D. A., Spencer, J. B., Guilcher, G. M. T., Bhatia, M., Abraham, A., Gomez-Lobo, V., Krishnamurti, L., & Meacham, L. R. (2024). Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 30(9), 912.e1-912.e13. https://doi.org/10.1016/j.jtct.2024.06.029
Publication Date
Columbia Affiliation
Shanthikumar, S., Gower, W. A., Cooke, K. R., Bergeron, A., Schultz, K. R., Barochia, A., Tamae-Kakazu, M., Charbek, E., Reardon, E. E., Calvo, C., Casey, A., Cheng, P. C., Cole, T. S., Davies, S. M., Das, S., De, A., Deterding, R. R., Liptzin, D. R., Mechinaud, F., … Goldfarb, S. B. (2024). Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink? Transplantation and Cellular Therapy, 30(8), 760–769. https://doi.org/10.1016/j.jtct.2024.05.012
Publication Date
Columbia Affiliation
Mata, J. R., Zahurak, M., Rosen, N., DeZern, A. E., Jones, R. J., & Ambinder, A. J. (2024). Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy, 30(6), 588–596. https://doi.org/10.1016/j.jtct.2024.03.018
Publication Date
Columbia Affiliation
Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M. M., Ayuk, F., Bader, P., Baez, J., Capellini, A., Choe, H., DeFilipp, Z., Eder, M., Eng, G., Etra, A., Gleich, S., Grupp, S. A., Hexner, E., … Ferrara, J. L. M. (2024). A Day 14 Endpoint for Acute GVHD Clinical Trials. Transplantation and Cellular Therapy, 30(4), 421–432. https://doi.org/10.1016/j.jtct.2024.01.079
Publication Date
Columbia Affiliation
Chakraborty, R., Yi, J., Rybicki, L., Preussler, J., Deol, A., Loren, A., Savani, B., Jim, H. S. L., Cerny, J., Reynolds, J., Whitten, J., Wingard, J. R., McGuirk, J. P., Uberti, J., Khera, N., Stiff, P., Jaglowski, S. M., Hashmi, S., Holtan, S. G., … Majhail, N. S. (2023). Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Transplantation and Cellular Therapy, 29(6), 388.e1-388.e6. https://doi.org/10.1016/j.jtct.2023.02.011
Publication Date
Columbia Affiliation
Putta, S., Young, B. A., Levine, J. E., Reshef, R., Nakamura, R., Strouse, C., Perales, M.-A., Howard, A., Pine, P., Shi, J., Zhang, P., Ho, V. T., & Saber, W. (2023). Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy, 29(3), 166.e1-166.e10. https://doi.org/10.1016/j.jtct.2022.11.024
Publication Date
Columbia Affiliation
Patel, C., Pasciolla, M., Abramova, R., Salerno, D., Gomez-Arteaga, A., Shore, T. B., Orfali, N., Mayer, S., Hsu, J., Phillips, A. A., Chaekal, O.-K., Satlin, M. J., Soave, R., Kodiyanplakkal, R. P. L., Drelick, A., Plate, M., & Besien, K. V. (2023). Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and Cellular Therapy, 29(2), 132.e1-132.e5. https://doi.org/10.1016/j.jtct.2022.10.023
Publication Date
Stenger, E., Xiang, Y., Wetzel, M., Gillespie, S., Chellapandian, D., Shah, R., Arnold, S. D., Bhatia, M., Chaudhury, S., Eckrich, M. J., Kanter, J., Kasow, K. A., Krajewski, J., Nickel, R. S., Ngwube, A. I., Olson, T. S., Rangarajan, H. G., Wobma, H., Guilcher, G. M. T., … Abraham, A. (2023). Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance. Transplantation and Cellular Therapy, 29(1), 47.e1-47.e10. https://doi.org/10.1016/j.jtct.2022.10.012
Publication Date
Columbia Affiliation
Landau, H. J., Orlando, E., Rodriguez, E. S., Applebaum, A., Mitchell, H.-R., Peled, J. U., Khan, N., Funnell, T., Chung, D., Scordo, M., Shah, G. L., LeStrange, N. J., Hambright, K. A., McElrath, C. M., Cazeau, N., Devlin, S. M., Perales, M.-A., van den Brink, M. R. M., & Giralt, S. A. (2022). Pilot Trial of Homebound Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(12), 832.e1-832.e7. https://doi.org/10.1016/j.jtct.2022.09.014
Publication Date
Columbia Affiliation
Otegbeye, F., Vina, M. A. F., Wang, T., Bolon, Y.-T., Lazaryan, A., Beitinjaneh, A., Bhatt, V. R., Castillo, P., Marsh, S. G. E., Hildebrandt, G. C., Assal, A., Brown, V. I., Hsu, J., Spellman, S., de Lima, M., & Lee, S. J. (2022). Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy, 28(8), 483.e1-483.e7. https://doi.org/10.1016/j.jtct.2022.05.034
Publication Date
Columbia Affiliation
Bansal, R., Park, H., Taborda, C. C., Gordillo, C., Mapara, M. Y., Assal, A., Uhlemann, A.-C., & Reshef, R. (2022). Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(3), 135–144. https://doi.org/10.1016/j.jtct.2021.12.015
Publication Date
Columbia Affiliation
Sidana, S., Kumar, S., Fraser, R., Estrada-Merly, N., Giralt, S., Agrawal, V., Anderson, L. D., Aljurf, M., Banerjee, R., Bashey, A., Battiwalla, M., Beitinjaneh, A., Chakraborty, R., Chhabra, S., Dhakal, B., Dholaria, B., Hashmi, S., Janakiram, M., Lee, C., … D’Souza, A. (2022). Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy, 28(2), 83.e1-83.e9. https://doi.org/10.1016/j.jtct.2021.10.022
Publication Date
Columbia Affiliation
Zou, J., Wang, T., He, M., Bolon, Y.-T., Gadalla, S. M., Marsh, S. G. E., Kuxhausen, M., Gale, R. P., Sharma, A., Assal, A., Prestidge, T., Aljurf, M., Cerny, J., Paczesny, S., Spellman, S. R., Lee, S. J., & Ciurea, S. O. (2022). Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. Transplantation and Cellular Therapy, 28(2), 107.e1-107.e8. https://doi.org/10.1016/j.jtct.2021.11.001
Publication Date
Columbia Affiliation
Macedo, R., Pasin, C., Ganetsky, A., Harle, D., Wang, X. K., Belay, K., Richman, L. P., Huffman, A. P., Vonderheide, R. H., Yates, A. J., Porter, D. L., Wang, Y., Zhang, Y., & Reshef, R. (2022). Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature. Transplantation and Cellular Therapy, 28(1), 18.e1-18.e10. https://doi.org/10.1016/j.jtct.2021.09.017
Publication Date
Columbia Affiliation